MedTrace Logo

Usefulness of FDG-PET for Advanced Cervical Cancer

NCT00146458 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2006-09-20

No results posted yet for this study

Summary

The objective of this study is to determinate whether the adding of FDG-PET is helpful in the treatment of advanced cervical cancer with concurrent chemoradiation.

Conditions

Interventions

PROCEDURE

18F-fluorodeoxyglucose positron emission tomography

Sponsors & Collaborators

  • National Science and Technology Council, Taiwan

    collaborator OTHER_GOV

  • Chang Gung Memorial Hospital

    lead OTHER

Principal Investigators

  • Chien-Sheng Tsai, M.D. · Department of Radiation Oncology, Chang Gung Memorial Hospital

  • Tin-Chang Chang, M.D., MPH. · Director of Division of Gynecologic Oncology, Chang Gung Memorial Hospital, Linkou Medical Center

  • Chyong-Huey Lai, M.D. · Chairman of Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Linkou Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
0 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-01-31
Completion
2007-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00146458 on ClinicalTrials.gov